Loading…

Single‐agent cladribine as an effective front‐line therapy for adults with Langerhans cell histiocytosis

Saved in:
Bibliographic Details
Published in:American journal of hematology 2021-05, Vol.96 (5), p.E146-E150
Main Authors: Goyal, Gaurav, Abeykoon, Jithma P., Hu, Marie, Young, Jason R., Shah, Mithun V., Bennani, N. Nora, Call, Timothy G., Hook, C. Christopher, Pardanani, Animesh, Inwards, David J., Vassallo, Robert, Ryu, Jay H., Tobin, W. Oliver, Koster, Matthew J., Davidge‐Pitts, Caroline J., Ravindran, Aishwarya, Rech, Karen L., Go, Ronald S.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4439-4bb901755b5ef971aee85a1b432a9b656cccc80c1128e15f2d7ca9737c6e36cb3
cites cdi_FETCH-LOGICAL-c4439-4bb901755b5ef971aee85a1b432a9b656cccc80c1128e15f2d7ca9737c6e36cb3
container_end_page E150
container_issue 5
container_start_page E146
container_title American journal of hematology
container_volume 96
creator Goyal, Gaurav
Abeykoon, Jithma P.
Hu, Marie
Young, Jason R.
Shah, Mithun V.
Bennani, N. Nora
Call, Timothy G.
Hook, C. Christopher
Pardanani, Animesh
Inwards, David J.
Vassallo, Robert
Ryu, Jay H.
Tobin, W. Oliver
Koster, Matthew J.
Davidge‐Pitts, Caroline J.
Ravindran, Aishwarya
Rech, Karen L.
Go, Ronald S.
description
doi_str_mv 10.1002/ajh.26119
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8044045</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2487154358</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4439-4bb901755b5ef971aee85a1b432a9b656cccc80c1128e15f2d7ca9737c6e36cb3</originalsourceid><addsrcrecordid>eNp1kcFqVDEUhoModqwufAEJuKmLaZOb5N5kI5SitjLgQl2H3My5czNkkjHJbZmdj-Az-iRmnLZYodmcwPn4OT8fQq8pOaWENGdmPZ42LaXqCZpRotq5bEXzFM0Ia2n9E3WEXuS8JoRSLslzdMSYYEpIPkP-qwsrD79__jIrCAVbb5bJ9S4ANhmbgGEYwBZ3DXhIMZQK-v2yjJDMdoeHmLBZTr5kfOPKiBcmrCCNJmRswXs8ulxctLsSs8sv0bPB-Ayvbucx-v7xw7eLy_niy6eri_PF3HLO1Jz3vSK0E6IXMKiOGgApDO05a4zqW9Ha-iSxlDYSqBiaZWeN6lhnW2Ct7dkxen_I3U79Bpa2FkvG621yG5N2OhqnH26CG_UqXmtJOCdc1ICT24AUf0yQi964vO9jAsQp64bLjgrOhKzo2__QdZxSqPV0IyglsgppKvXuQNkUc04w3B9Did471NWh_uuwsm_-vf6evJNWgbMDcOM87B5P0uefLw-RfwB_TKoF</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2511081092</pqid></control><display><type>article</type><title>Single‐agent cladribine as an effective front‐line therapy for adults with Langerhans cell histiocytosis</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Goyal, Gaurav ; Abeykoon, Jithma P. ; Hu, Marie ; Young, Jason R. ; Shah, Mithun V. ; Bennani, N. Nora ; Call, Timothy G. ; Hook, C. Christopher ; Pardanani, Animesh ; Inwards, David J. ; Vassallo, Robert ; Ryu, Jay H. ; Tobin, W. Oliver ; Koster, Matthew J. ; Davidge‐Pitts, Caroline J. ; Ravindran, Aishwarya ; Rech, Karen L. ; Go, Ronald S.</creator><creatorcontrib>Goyal, Gaurav ; Abeykoon, Jithma P. ; Hu, Marie ; Young, Jason R. ; Shah, Mithun V. ; Bennani, N. Nora ; Call, Timothy G. ; Hook, C. Christopher ; Pardanani, Animesh ; Inwards, David J. ; Vassallo, Robert ; Ryu, Jay H. ; Tobin, W. Oliver ; Koster, Matthew J. ; Davidge‐Pitts, Caroline J. ; Ravindran, Aishwarya ; Rech, Karen L. ; Go, Ronald S. ; Mayo Clinic-University of Alabama at Birmingham Histiocytosis Working Group ; Mayo Clinic‐University of Alabama at Birmingham Histiocytosis Working Group</creatorcontrib><identifier>ISSN: 0361-8609</identifier><identifier>EISSN: 1096-8652</identifier><identifier>DOI: 10.1002/ajh.26119</identifier><identifier>PMID: 33539584</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley &amp; Sons, Inc</publisher><subject>Adult ; Aged ; Autoimmune diseases ; Cladribine ; Cladribine - administration &amp; dosage ; Cladribine - pharmacology ; Cladribine - therapeutic use ; Combined Modality Therapy ; Disease Progression ; Drug Evaluation ; Female ; Hematology ; Histiocytosis ; Histiocytosis, Langerhans-Cell - diagnostic imaging ; Histiocytosis, Langerhans-Cell - drug therapy ; Histiocytosis, Langerhans-Cell - physiopathology ; Histiocytosis, Langerhans-Cell - therapy ; Humans ; Kaplan-Meier Estimate ; Langerhans cell histiocytosis ; Magnetic Resonance Imaging ; Male ; MAP Kinase Signaling System - drug effects ; Middle Aged ; Mutation, Missense ; Point Mutation ; Positron Emission Tomography Computed Tomography ; Progression-Free Survival ; Proto-Oncogene Proteins B-raf - genetics ; Pulmonary Diffusing Capacity - drug effects ; Retrospective Studies ; Treatment Outcome ; Young Adult</subject><ispartof>American journal of hematology, 2021-05, Vol.96 (5), p.E146-E150</ispartof><rights>2021 Wiley Periodicals LLC.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4439-4bb901755b5ef971aee85a1b432a9b656cccc80c1128e15f2d7ca9737c6e36cb3</citedby><cites>FETCH-LOGICAL-c4439-4bb901755b5ef971aee85a1b432a9b656cccc80c1128e15f2d7ca9737c6e36cb3</cites><orcidid>0000-0002-6894-9277 ; 0000-0002-9084-4148 ; 0000-0002-9576-2272 ; 0000-0003-4503-440X ; 0000-0001-6148-5177 ; 0000-0003-3939-6252</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,777,781,882,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33539584$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Goyal, Gaurav</creatorcontrib><creatorcontrib>Abeykoon, Jithma P.</creatorcontrib><creatorcontrib>Hu, Marie</creatorcontrib><creatorcontrib>Young, Jason R.</creatorcontrib><creatorcontrib>Shah, Mithun V.</creatorcontrib><creatorcontrib>Bennani, N. Nora</creatorcontrib><creatorcontrib>Call, Timothy G.</creatorcontrib><creatorcontrib>Hook, C. Christopher</creatorcontrib><creatorcontrib>Pardanani, Animesh</creatorcontrib><creatorcontrib>Inwards, David J.</creatorcontrib><creatorcontrib>Vassallo, Robert</creatorcontrib><creatorcontrib>Ryu, Jay H.</creatorcontrib><creatorcontrib>Tobin, W. Oliver</creatorcontrib><creatorcontrib>Koster, Matthew J.</creatorcontrib><creatorcontrib>Davidge‐Pitts, Caroline J.</creatorcontrib><creatorcontrib>Ravindran, Aishwarya</creatorcontrib><creatorcontrib>Rech, Karen L.</creatorcontrib><creatorcontrib>Go, Ronald S.</creatorcontrib><creatorcontrib>Mayo Clinic-University of Alabama at Birmingham Histiocytosis Working Group</creatorcontrib><creatorcontrib>Mayo Clinic‐University of Alabama at Birmingham Histiocytosis Working Group</creatorcontrib><title>Single‐agent cladribine as an effective front‐line therapy for adults with Langerhans cell histiocytosis</title><title>American journal of hematology</title><addtitle>Am J Hematol</addtitle><subject>Adult</subject><subject>Aged</subject><subject>Autoimmune diseases</subject><subject>Cladribine</subject><subject>Cladribine - administration &amp; dosage</subject><subject>Cladribine - pharmacology</subject><subject>Cladribine - therapeutic use</subject><subject>Combined Modality Therapy</subject><subject>Disease Progression</subject><subject>Drug Evaluation</subject><subject>Female</subject><subject>Hematology</subject><subject>Histiocytosis</subject><subject>Histiocytosis, Langerhans-Cell - diagnostic imaging</subject><subject>Histiocytosis, Langerhans-Cell - drug therapy</subject><subject>Histiocytosis, Langerhans-Cell - physiopathology</subject><subject>Histiocytosis, Langerhans-Cell - therapy</subject><subject>Humans</subject><subject>Kaplan-Meier Estimate</subject><subject>Langerhans cell histiocytosis</subject><subject>Magnetic Resonance Imaging</subject><subject>Male</subject><subject>MAP Kinase Signaling System - drug effects</subject><subject>Middle Aged</subject><subject>Mutation, Missense</subject><subject>Point Mutation</subject><subject>Positron Emission Tomography Computed Tomography</subject><subject>Progression-Free Survival</subject><subject>Proto-Oncogene Proteins B-raf - genetics</subject><subject>Pulmonary Diffusing Capacity - drug effects</subject><subject>Retrospective Studies</subject><subject>Treatment Outcome</subject><subject>Young Adult</subject><issn>0361-8609</issn><issn>1096-8652</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp1kcFqVDEUhoModqwufAEJuKmLaZOb5N5kI5SitjLgQl2H3My5czNkkjHJbZmdj-Az-iRmnLZYodmcwPn4OT8fQq8pOaWENGdmPZ42LaXqCZpRotq5bEXzFM0Ia2n9E3WEXuS8JoRSLslzdMSYYEpIPkP-qwsrD79__jIrCAVbb5bJ9S4ANhmbgGEYwBZ3DXhIMZQK-v2yjJDMdoeHmLBZTr5kfOPKiBcmrCCNJmRswXs8ulxctLsSs8sv0bPB-Ayvbucx-v7xw7eLy_niy6eri_PF3HLO1Jz3vSK0E6IXMKiOGgApDO05a4zqW9Ha-iSxlDYSqBiaZWeN6lhnW2Ct7dkxen_I3U79Bpa2FkvG621yG5N2OhqnH26CG_UqXmtJOCdc1ICT24AUf0yQi964vO9jAsQp64bLjgrOhKzo2__QdZxSqPV0IyglsgppKvXuQNkUc04w3B9Did471NWh_uuwsm_-vf6evJNWgbMDcOM87B5P0uefLw-RfwB_TKoF</recordid><startdate>20210501</startdate><enddate>20210501</enddate><creator>Goyal, Gaurav</creator><creator>Abeykoon, Jithma P.</creator><creator>Hu, Marie</creator><creator>Young, Jason R.</creator><creator>Shah, Mithun V.</creator><creator>Bennani, N. Nora</creator><creator>Call, Timothy G.</creator><creator>Hook, C. Christopher</creator><creator>Pardanani, Animesh</creator><creator>Inwards, David J.</creator><creator>Vassallo, Robert</creator><creator>Ryu, Jay H.</creator><creator>Tobin, W. Oliver</creator><creator>Koster, Matthew J.</creator><creator>Davidge‐Pitts, Caroline J.</creator><creator>Ravindran, Aishwarya</creator><creator>Rech, Karen L.</creator><creator>Go, Ronald S.</creator><general>John Wiley &amp; Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-6894-9277</orcidid><orcidid>https://orcid.org/0000-0002-9084-4148</orcidid><orcidid>https://orcid.org/0000-0002-9576-2272</orcidid><orcidid>https://orcid.org/0000-0003-4503-440X</orcidid><orcidid>https://orcid.org/0000-0001-6148-5177</orcidid><orcidid>https://orcid.org/0000-0003-3939-6252</orcidid></search><sort><creationdate>20210501</creationdate><title>Single‐agent cladribine as an effective front‐line therapy for adults with Langerhans cell histiocytosis</title><author>Goyal, Gaurav ; Abeykoon, Jithma P. ; Hu, Marie ; Young, Jason R. ; Shah, Mithun V. ; Bennani, N. Nora ; Call, Timothy G. ; Hook, C. Christopher ; Pardanani, Animesh ; Inwards, David J. ; Vassallo, Robert ; Ryu, Jay H. ; Tobin, W. Oliver ; Koster, Matthew J. ; Davidge‐Pitts, Caroline J. ; Ravindran, Aishwarya ; Rech, Karen L. ; Go, Ronald S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4439-4bb901755b5ef971aee85a1b432a9b656cccc80c1128e15f2d7ca9737c6e36cb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Autoimmune diseases</topic><topic>Cladribine</topic><topic>Cladribine - administration &amp; dosage</topic><topic>Cladribine - pharmacology</topic><topic>Cladribine - therapeutic use</topic><topic>Combined Modality Therapy</topic><topic>Disease Progression</topic><topic>Drug Evaluation</topic><topic>Female</topic><topic>Hematology</topic><topic>Histiocytosis</topic><topic>Histiocytosis, Langerhans-Cell - diagnostic imaging</topic><topic>Histiocytosis, Langerhans-Cell - drug therapy</topic><topic>Histiocytosis, Langerhans-Cell - physiopathology</topic><topic>Histiocytosis, Langerhans-Cell - therapy</topic><topic>Humans</topic><topic>Kaplan-Meier Estimate</topic><topic>Langerhans cell histiocytosis</topic><topic>Magnetic Resonance Imaging</topic><topic>Male</topic><topic>MAP Kinase Signaling System - drug effects</topic><topic>Middle Aged</topic><topic>Mutation, Missense</topic><topic>Point Mutation</topic><topic>Positron Emission Tomography Computed Tomography</topic><topic>Progression-Free Survival</topic><topic>Proto-Oncogene Proteins B-raf - genetics</topic><topic>Pulmonary Diffusing Capacity - drug effects</topic><topic>Retrospective Studies</topic><topic>Treatment Outcome</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Goyal, Gaurav</creatorcontrib><creatorcontrib>Abeykoon, Jithma P.</creatorcontrib><creatorcontrib>Hu, Marie</creatorcontrib><creatorcontrib>Young, Jason R.</creatorcontrib><creatorcontrib>Shah, Mithun V.</creatorcontrib><creatorcontrib>Bennani, N. Nora</creatorcontrib><creatorcontrib>Call, Timothy G.</creatorcontrib><creatorcontrib>Hook, C. Christopher</creatorcontrib><creatorcontrib>Pardanani, Animesh</creatorcontrib><creatorcontrib>Inwards, David J.</creatorcontrib><creatorcontrib>Vassallo, Robert</creatorcontrib><creatorcontrib>Ryu, Jay H.</creatorcontrib><creatorcontrib>Tobin, W. Oliver</creatorcontrib><creatorcontrib>Koster, Matthew J.</creatorcontrib><creatorcontrib>Davidge‐Pitts, Caroline J.</creatorcontrib><creatorcontrib>Ravindran, Aishwarya</creatorcontrib><creatorcontrib>Rech, Karen L.</creatorcontrib><creatorcontrib>Go, Ronald S.</creatorcontrib><creatorcontrib>Mayo Clinic-University of Alabama at Birmingham Histiocytosis Working Group</creatorcontrib><creatorcontrib>Mayo Clinic‐University of Alabama at Birmingham Histiocytosis Working Group</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>American journal of hematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Goyal, Gaurav</au><au>Abeykoon, Jithma P.</au><au>Hu, Marie</au><au>Young, Jason R.</au><au>Shah, Mithun V.</au><au>Bennani, N. Nora</au><au>Call, Timothy G.</au><au>Hook, C. Christopher</au><au>Pardanani, Animesh</au><au>Inwards, David J.</au><au>Vassallo, Robert</au><au>Ryu, Jay H.</au><au>Tobin, W. Oliver</au><au>Koster, Matthew J.</au><au>Davidge‐Pitts, Caroline J.</au><au>Ravindran, Aishwarya</au><au>Rech, Karen L.</au><au>Go, Ronald S.</au><aucorp>Mayo Clinic-University of Alabama at Birmingham Histiocytosis Working Group</aucorp><aucorp>Mayo Clinic‐University of Alabama at Birmingham Histiocytosis Working Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Single‐agent cladribine as an effective front‐line therapy for adults with Langerhans cell histiocytosis</atitle><jtitle>American journal of hematology</jtitle><addtitle>Am J Hematol</addtitle><date>2021-05-01</date><risdate>2021</risdate><volume>96</volume><issue>5</issue><spage>E146</spage><epage>E150</epage><pages>E146-E150</pages><issn>0361-8609</issn><eissn>1096-8652</eissn><cop>Hoboken, USA</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>33539584</pmid><doi>10.1002/ajh.26119</doi><tpages>49</tpages><orcidid>https://orcid.org/0000-0002-6894-9277</orcidid><orcidid>https://orcid.org/0000-0002-9084-4148</orcidid><orcidid>https://orcid.org/0000-0002-9576-2272</orcidid><orcidid>https://orcid.org/0000-0003-4503-440X</orcidid><orcidid>https://orcid.org/0000-0001-6148-5177</orcidid><orcidid>https://orcid.org/0000-0003-3939-6252</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0361-8609
ispartof American journal of hematology, 2021-05, Vol.96 (5), p.E146-E150
issn 0361-8609
1096-8652
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8044045
source Wiley-Blackwell Read & Publish Collection
subjects Adult
Aged
Autoimmune diseases
Cladribine
Cladribine - administration & dosage
Cladribine - pharmacology
Cladribine - therapeutic use
Combined Modality Therapy
Disease Progression
Drug Evaluation
Female
Hematology
Histiocytosis
Histiocytosis, Langerhans-Cell - diagnostic imaging
Histiocytosis, Langerhans-Cell - drug therapy
Histiocytosis, Langerhans-Cell - physiopathology
Histiocytosis, Langerhans-Cell - therapy
Humans
Kaplan-Meier Estimate
Langerhans cell histiocytosis
Magnetic Resonance Imaging
Male
MAP Kinase Signaling System - drug effects
Middle Aged
Mutation, Missense
Point Mutation
Positron Emission Tomography Computed Tomography
Progression-Free Survival
Proto-Oncogene Proteins B-raf - genetics
Pulmonary Diffusing Capacity - drug effects
Retrospective Studies
Treatment Outcome
Young Adult
title Single‐agent cladribine as an effective front‐line therapy for adults with Langerhans cell histiocytosis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T11%3A58%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Single%E2%80%90agent%20cladribine%20as%20an%20effective%20front%E2%80%90line%20therapy%20for%20adults%20with%20Langerhans%20cell%20histiocytosis&rft.jtitle=American%20journal%20of%20hematology&rft.au=Goyal,%20Gaurav&rft.aucorp=Mayo%20Clinic-University%20of%20Alabama%20at%20Birmingham%20Histiocytosis%20Working%20Group&rft.date=2021-05-01&rft.volume=96&rft.issue=5&rft.spage=E146&rft.epage=E150&rft.pages=E146-E150&rft.issn=0361-8609&rft.eissn=1096-8652&rft_id=info:doi/10.1002/ajh.26119&rft_dat=%3Cproquest_pubme%3E2487154358%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4439-4bb901755b5ef971aee85a1b432a9b656cccc80c1128e15f2d7ca9737c6e36cb3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2511081092&rft_id=info:pmid/33539584&rfr_iscdi=true